Ajit Shetty

Ajit S.
Shetty currently serves as Chairman at Mcb Forum and Rejuvenate Biomed, Director at Soudal NV, Independent Director at Actinium Pharmaceuticals, Inc., Independent Non-Executive Director at YishengBio Co., Ltd., Trustee at Carnegie Mellon University, Member of the Supervisory Board at Cilag GmbH International, and Member of the Governors Board at GS1 AISBL.
Former positions include Chairman at Janssen Pharmaceuticals, Inc. (2004–2012), Chairman at Mithra Pharmaceuticals SA (2021–2022), Chairman at Vlaams Instituut voor Biotechnologie - Flanders Institute, Chairman at Janssen Pharmaceutica NV (2008–2017), Independent Director at Agile Therapeutics, Inc. (2016–2023), Director at Saama Technologies, Inc., Director at reMYND NV, Director at Optimal Strategix Group, Inc., Independent Non-Executive Director at LakeShore Biopharma Co., Ltd. (2021–2023), and Head-Enterprise Supply Chain at Johnson & Johnson (2007–2012).
Education includes a Doctorate (1972) and undergraduate degree from Trinity College, Cambridge, and an MBA from Carnegie Mellon University (1974).